The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Menzaghi Frederique Ph.d. since 2015.
This trader's CIK number is 1597152.
At the time of last reporting, Menzaghi Frederique Ph.d. was the Chief Scientific Off,SVP-R&D of Cara Therapeutics, Inc.. (stock ticker symbol CARA).
Also see all insider trading activities at Cara Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | CARA | 0 | $0 | 12,528 | $89,971 | 0 | $0 |
| 2022 | CARA | 0 | $0 | 5,290 | $60,759 | 0 | $0 |
| 2021 | CARA | 0 | $0 | 12,208 | $211,710 | 0 | $0 |
| 2020 | CARA | 0 | $0 | 15,706 | $243,911 | 0 | $0 |
| 2019 | CARA | 0 | $0 | 124,393 | $2,650,259 | 0 | $0 |
| 2018 | CARA | 0 | $0 | 48,000 | $809,699 | 50,000 | $104,500 |
| 2017 | CARA | 0 | $0 | 6,000 | $90,000 | 20,000 | $49,600 |
| 2016 | CARA | 0 | $0 | 18,000 | $209,050 | 0 | $0 |
| 2015 | CARA | 0 | $0 | 39,000 | $633,330 | 20,000 | $5,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-23 | CARA | Sale | 2,993 | 3.51 | 10,505 |
| 2023-04-04 | CARA | Sale | 2,733 | 4.91 | 13,419 |
| 2023-03-03 | CARA | Sale | 6,802 | 9.71 | 66,047 |
| 2022-12-21 | CARA | Sale | 3,506 | 11.27 | 39,512 |
| 2022-04-01 | CARA | Sale | 1,784 | 11.91 | 21,247 |
| 2021-08-30 | CARA | Sale | 3,847 | 14.20 | 54,627 |
| 2021-03-05 | CARA | Sale | 3,358 | 17.98 | 60,376 |
| 2021-02-25 | CARA | Sale | 5,003 | 19.33 | 96,707 |
| 2020-12-30 | CARA | Sale | 2,812 | 15.30 | 43,023 |
| 2020-04-21 | CARA | Sale | 12,894 | 15.58 | 200,888 |
| 2019-10-25 | CARA | Sale | 4,000 | 19.91 | 79,640 |
| 2019-10-18 | CARA | Sale | 4,000 | 19.33 | 77,320 |
| 2019-10-11 | CARA | Sale | 4,000 | 18.70 | 74,800 |
| 2019-10-04 | CARA | Sale | 4,000 | 19.19 | 76,760 |
| 2019-09-03 | CARA | Sale | 20,000 | 22.92 | 458,400 |
| 2019-08-01 | CARA | Sale | 20,000 | 23.24 | 464,799 |
| 2019-07-17 | CARA | Sale | 8,996 | 27.50 | 247,390 |
| 2019-07-01 | CARA | Sale | 20,000 | 21.90 | 438,000 |
| 2019-05-29 | CARA | Sale | 11,397 | 21.19 | 241,502 |
| 2019-03-12 | CARA | Sale | 3,197 | 17.50 | 55,947 |
| 2019-03-13 | CARA | Sale | 16,803 | 18.87 | 317,072 |
| 2019-02-28 | CARA | Sale | 1,500 | 17.50 | 26,250 |
| 2019-02-25 | CARA | Sale | 2,200 | 17.50 | 38,500 |
| 2018-12-28 | CARA | Sale | 4,300 | 12.53 | 53,879 |
| 2018-12-03 | CARA | Sale | 3,000 | 18.36 | 55,080 |
| 2018-11-01 | CARA | Option Ex | 40,000 | 2.05 | 82,000 |
| 2018-11-01 | CARA | Sale | 3,000 | 18.77 | 56,310 |
| 2018-08-06 | CARA | Option Ex | 10,000 | 2.25 | 22,500 |
| 2018-10-01 | CARA | Sale | 3,000 | 23.99 | 71,970 |
| 2018-09-04 | CARA | Sale | 3,000 | 19.81 | 59,429 |
| 2018-08-20 | CARA | Sale | 3,000 | 18.89 | 56,670 |
| 2018-07-02 | CARA | Sale | 3,000 | 19.00 | 57,000 |
| 2018-06-01 | CARA | Sale | 3,000 | 15.49 | 46,470 |
| 2018-05-23 | CARA | Sale | 9,000 | 15.19 | 136,710 |
| 2018-02-15 | CARA | Sale | 3,000 | 15.02 | 45,060 |
| 2018-01-24 | CARA | Sale | 15,000 | 15.00 | 225,000 |
| 2017-11-07 | CARA | Option Ex | 20,000 | 2.48 | 49,600 |
| 2017-08-04 | CARA | Sale | 3,000 | 15.00 | 45,000 |
| 2017-07-14 | CARA | Sale | 3,000 | 15.00 | 45,000 |
| 2016-04-20 | CARA | Sale | 6,000 | 9.00 | 54,000 |
| 2016-02-01 | CARA | Sale | 5,000 | 9.05 | 45,250 |
| 2016-02-03 | CARA | Sale | 1,000 | 9.00 | 9,000 |
| 2016-01-04 | CARA | Sale | 6,000 | 16.80 | 100,800 |
| 2015-12-01 | CARA | Sale | 6,000 | 16.21 | 97,260 |
| 2015-11-02 | CARA | Sale | 6,000 | 14.26 | 85,560 |
| 2015-10-01 | CARA | Sale | 6,000 | 14.12 | 84,690 |
| 2015-09-01 | CARA | Sale | 7,000 | 18.63 | 130,410 |
| 2015-08-03 | CARA | Sale | 7,000 | 21.41 | 149,870 |
| 2015-07-01 | CARA | Sale | 7,000 | 12.22 | 85,540 |
| 2015-03-09 | CARA | Option Ex | 20,000 | .25 | 5,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D of Cara Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.